The global Codeine market size was valued at US$ 267 million in 2023. With growing demand in downstream market, the Codeine is forecast to a readjusted size of US$ 177 million by 2030 with a CAGR of -5.7% during review period.
The research report highlights the growth potential of the global Codeine market. Codeine are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Codeine. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Codeine market.
Codeine is an opiate used to treat pain, coughing, and diarrhea. It is typically used to treat mild to moderate degrees of pain.
Market competition is intense. Taiji, Mallinckrodt, TEVA, Johnson & Johnson, Medreich, Sanofi Aventis, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers. For the major company of Codeine, Taiji and Mallinckrodt accounted for about 16% market share respectively in recent years.
Key Features:
The report on Codeine market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Codeine market. It may include historical data, market segmentation by Ingredient (e.g., Single-ingredient Codeine, Multi-ingredient Medications), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Codeine market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Codeine market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Codeine industry. This include advancements in Codeine technology, Codeine new entrants, Codeine new investment, and other innovations that are shaping the future of Codeine.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Codeine market. It includes factors influencing customer ' purchasing decisions, preferences for Codeine product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Codeine market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Codeine market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Codeine market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Codeine industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Codeine market.
Market Segmentation:
Codeine market is split by Ingredient and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Ingredient, and by Application in terms of volume and value.
Segmentation by ingredient
Single-ingredient Codeine
Multi-ingredient Medications
Segmentation by application
Narcotic Analgesic
Antitussive
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Taiji
Mallinckrodt
TEVA
Johnson & Johnson
Medreich
Sanofi Aventis
Cipla
Hikma
Pharmaceutical Associates
Novartis
Apotex
Mylan
Aristo Pharma GmbH
Lannett Company
Laboratoire Riva
Key Questions Addressed in this Report
What is the 10-year outlook for the global Codeine market?
What factors are driving Codeine market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Codeine market opportunities vary by end market size?
How does Codeine break out ingredient, application?
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Codeine Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Codeine by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Codeine by Country/Region, 2019, 2023 & 2030
2.2 Codeine Segment by Ingredient
2.2.1 Single-ingredient Codeine
2.2.2 Multi-ingredient Medications
2.3 Codeine Sales by Ingredient
2.3.1 Global Codeine Sales Market Share by Ingredient (2019-2024)
2.3.2 Global Codeine Revenue and Market Share by Ingredient (2019-2024)
2.3.3 Global Codeine Sale Price by Ingredient (2019-2024)
2.4 Codeine Segment by Application
2.4.1 Narcotic Analgesic
2.4.2 Antitussive
2.4.3 Others
2.5 Codeine Sales by Application
2.5.1 Global Codeine Sale Market Share by Application (2019-2024)
2.5.2 Global Codeine Revenue and Market Share by Application (2019-2024)
2.5.3 Global Codeine Sale Price by Application (2019-2024)
3 Global Codeine by Company
3.1 Global Codeine Breakdown Data by Company
3.1.1 Global Codeine Annual Sales by Company (2019-2024)
3.1.2 Global Codeine Sales Market Share by Company (2019-2024)
3.2 Global Codeine Annual Revenue by Company (2019-2024)
3.2.1 Global Codeine Revenue by Company (2019-2024)
3.2.2 Global Codeine Revenue Market Share by Company (2019-2024)
3.3 Global Codeine Sale Price by Company
3.4 Key Manufacturers Codeine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Codeine Product Location Distribution
3.4.2 Players Codeine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Codeine by Geographic Region
4.1 World Historic Codeine Market Size by Geographic Region (2019-2024)
4.1.1 Global Codeine Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Codeine Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Codeine Market Size by Country/Region (2019-2024)
4.2.1 Global Codeine Annual Sales by Country/Region (2019-2024)
4.2.2 Global Codeine Annual Revenue by Country/Region (2019-2024)
4.3 Americas Codeine Sales Growth
4.4 APAC Codeine Sales Growth
4.5 Europe Codeine Sales Growth
4.6 Middle East & Africa Codeine Sales Growth
5 Americas
5.1 Americas Codeine Sales by Country
5.1.1 Americas Codeine Sales by Country (2019-2024)
5.1.2 Americas Codeine Revenue by Country (2019-2024)
5.2 Americas Codeine Sales by Ingredient
5.3 Americas Codeine Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Codeine Sales by Region
6.1.1 APAC Codeine Sales by Region (2019-2024)
6.1.2 APAC Codeine Revenue by Region (2019-2024)
6.2 APAC Codeine Sales by Ingredient
6.3 APAC Codeine Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Codeine by Country
7.1.1 Europe Codeine Sales by Country (2019-2024)
7.1.2 Europe Codeine Revenue by Country (2019-2024)
7.2 Europe Codeine Sales by Ingredient
7.3 Europe Codeine Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Codeine by Country
8.1.1 Middle East & Africa Codeine Sales by Country (2019-2024)
8.1.2 Middle East & Africa Codeine Revenue by Country (2019-2024)
8.2 Middle East & Africa Codeine Sales by Ingredient
8.3 Middle East & Africa Codeine Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Codeine
10.3 Manufacturing Process Analysis of Codeine
10.4 Industry Chain Structure of Codeine
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Codeine Distributors
11.3 Codeine Customer
12 World Forecast Review for Codeine by Geographic Region
12.1 Global Codeine Market Size Forecast by Region
12.1.1 Global Codeine Forecast by Region (2025-2030)
12.1.2 Global Codeine Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Codeine Forecast by Ingredient
12.7 Global Codeine Forecast by Application
13 Key Players Analysis
13.1 Taiji
13.1.1 Taiji Company Information
13.1.2 Taiji Codeine Product Portfolios and Specifications
13.1.3 Taiji Codeine Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Taiji Main Business Overview
13.1.5 Taiji Latest Developments
13.2 Mallinckrodt
13.2.1 Mallinckrodt Company Information
13.2.2 Mallinckrodt Codeine Product Portfolios and Specifications
13.2.3 Mallinckrodt Codeine Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Mallinckrodt Main Business Overview
13.2.5 Mallinckrodt Latest Developments
13.3 TEVA
13.3.1 TEVA Company Information
13.3.2 TEVA Codeine Product Portfolios and Specifications
13.3.3 TEVA Codeine Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 TEVA Main Business Overview
13.3.5 TEVA Latest Developments
13.4 Johnson & Johnson
13.4.1 Johnson & Johnson Company Information
13.4.2 Johnson & Johnson Codeine Product Portfolios and Specifications
13.4.3 Johnson & Johnson Codeine Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Johnson & Johnson Main Business Overview
13.4.5 Johnson & Johnson Latest Developments
13.5 Medreich
13.5.1 Medreich Company Information
13.5.2 Medreich Codeine Product Portfolios and Specifications
13.5.3 Medreich Codeine Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Medreich Main Business Overview
13.5.5 Medreich Latest Developments
13.6 Sanofi Aventis
13.6.1 Sanofi Aventis Company Information
13.6.2 Sanofi Aventis Codeine Product Portfolios and Specifications
13.6.3 Sanofi Aventis Codeine Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Sanofi Aventis Main Business Overview
13.6.5 Sanofi Aventis Latest Developments
13.7 Cipla
13.7.1 Cipla Company Information
13.7.2 Cipla Codeine Product Portfolios and Specifications
13.7.3 Cipla Codeine Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 Cipla Main Business Overview
13.7.5 Cipla Latest Developments
13.8 Hikma
13.8.1 Hikma Company Information
13.8.2 Hikma Codeine Product Portfolios and Specifications
13.8.3 Hikma Codeine Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 Hikma Main Business Overview
13.8.5 Hikma Latest Developments
13.9 Pharmaceutical Associates
13.9.1 Pharmaceutical Associates Company Information
13.9.2 Pharmaceutical Associates Codeine Product Portfolios and Specifications
13.9.3 Pharmaceutical Associates Codeine Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 Pharmaceutical Associates Main Business Overview
13.9.5 Pharmaceutical Associates Latest Developments
13.10 Novartis
13.10.1 Novartis Company Information
13.10.2 Novartis Codeine Product Portfolios and Specifications
13.10.3 Novartis Codeine Sales, Revenue, Price and Gross Margin (2019-2024)
13.10.4 Novartis Main Business Overview
13.10.5 Novartis Latest Developments
13.11 Apotex
13.11.1 Apotex Company Information
13.11.2 Apotex Codeine Product Portfolios and Specifications
13.11.3 Apotex Codeine Sales, Revenue, Price and Gross Margin (2019-2024)
13.11.4 Apotex Main Business Overview
13.11.5 Apotex Latest Developments
13.12 Mylan
13.12.1 Mylan Company Information
13.12.2 Mylan Codeine Product Portfolios and Specifications
13.12.3 Mylan Codeine Sales, Revenue, Price and Gross Margin (2019-2024)
13.12.4 Mylan Main Business Overview
13.12.5 Mylan Latest Developments
13.13 Aristo Pharma GmbH
13.13.1 Aristo Pharma GmbH Company Information
13.13.2 Aristo Pharma GmbH Codeine Product Portfolios and Specifications
13.13.3 Aristo Pharma GmbH Codeine Sales, Revenue, Price and Gross Margin (2019-2024)
13.13.4 Aristo Pharma GmbH Main Business Overview
13.13.5 Aristo Pharma GmbH Latest Developments
13.14 Lannett Company
13.14.1 Lannett Company Company Information
13.14.2 Lannett Company Codeine Product Portfolios and Specifications
13.14.3 Lannett Company Codeine Sales, Revenue, Price and Gross Margin (2019-2024)
13.14.4 Lannett Company Main Business Overview
13.14.5 Lannett Company Latest Developments
13.15 Laboratoire Riva
13.15.1 Laboratoire Riva Company Information
13.15.2 Laboratoire Riva Codeine Product Portfolios and Specifications
13.15.3 Laboratoire Riva Codeine Sales, Revenue, Price and Gross Margin (2019-2024)
13.15.4 Laboratoire Riva Main Business Overview
13.15.5 Laboratoire Riva Latest Developments
14 Research Findings and Conclusion
听
听
*If Applicable.
